Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal Cancer
- 6 Downloads
Definitive chemoradiation (CRT) results in high cure rates of anal cancer, with advanced radiation (RT) techniques improving toxicity. However, there is limited data regarding these patients’ sexual function (SF), quality of life (QOL), and mood. We hypothesized that anal cancer treatment would result in detrimental effects on SF, QOL, and mood.
We prospectively surveyed patients with anal cancer treated with definitive CRT. We assessed SF for women with the Female Sexual Function Index (FSFI) and for men with the International Index of Erectile Function (IIEF). For all patients, we assessed QOL using EORTC QLQ-C30 and CR29 and mood using the Hospital Anxiety and Depression Scale (HADS). We reported descriptive statistics for SF, QOL, and mood and used univariate analysis to evaluate predictors of SF for women.
Of 50 eligible patients, 84% completed the surveys. Median time from RT until survey was 36 months (1–97 months). Women (n = 34) reported poor SF overall (mean FSFI score = 15, scale 2–36, standard deviation (SD) 10.4). Most women reported poor SF related to satisfaction, desire, orgasm, arousal, pain, and lubrication. Men (n = 8) also had poor overall satisfaction (mean IIEF score = 6.1, scale 2–10, SD 3.6). Men reported poor erectile function and lower satisfaction with intercourse. Mean QLQ-C30 QOL score was 86.5 (SD 16.3). Results from EORTC QLQ-CR-20 demonstrated patients experienced poor sexual interest. Per HADS, 2.5% reported depression and 18% anxiety.
Patients with anal cancer experience sexual dysfunction after RT, with QOL and mood symptoms similar to patients with other cancers. Our data support the need for ongoing efforts to understand and address issues with SF, QOL, and mood following RT for these patients.
KeywordsAnal cancer Sexual function Quality of life Mood Depression Anxiety
This study is supported by the Patty Brisben Foundation (awarded to JYW and LCD) and a Rare Cancer Genetics Registry Grant (NIH 4R01CA160233-05, PI: Dianne Finkelstein).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 2.Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14:2527–39.CrossRefGoogle Scholar
- 3.Bartelink H, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040–9.CrossRefGoogle Scholar
- 10.Jensen PT, Froeding L. Pelvic radiotherapy and sexual function in women. Transl Androl Urol. 2015;4:186.Google Scholar
- 19.Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86:27–33.CrossRefGoogle Scholar
- 36.Fayers PM, Machin D. Quality of life: the assessment, analysis and interpretation of patientreported outcomes. Wiley; 2013.Google Scholar
- 42.Wo JY, Drapek LC, Niemierko A, Silvia BL, Russo AL, Gray PJ, et al. Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation. Int J Rad Oncol Biol Phys. 2017;96(2):E528–9.Google Scholar